tiprankstipranks
Trending News
More News >
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
US Market

Bicara Therapeutics Inc. (BCAX) Income Statement

Compare
71 Followers

Bicara Therapeutics Inc. Income Statement

Last quarter (Q3 2025), Bicara Therapeutics Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Bicara Therapeutics Inc.'s net income was $-36.33M. See Bicara Therapeutics Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 82.39M$ 39.89M$ 37.66M
Depreciation and Amortization
$ 56.00K$ 19.00K$ 10.00K
EBITDA
$ -82.33M$ -39.87M$ -37.72M
Operating Income
$ -82.39M$ -39.89M$ -37.66M
Other Income/Expenses
$ 14.58M$ -12.09M$ -188.00K
Pretax Income
$ -67.81M$ -51.98M$ -37.84M
Net Income
$ -68.00M$ -51.98M$ -37.84M
Per Share Metrics
Basic EPS
$ -1.25$ -1.00$ -0.73
Diluted EPS
$ -1.25$ -1.00$ -0.73
Weighted Average Shares Outstanding
54.42M 51.76M 51.76M
Weighted Average Shares Outstanding (Diluted)
54.42M 51.76M 51.76M
Currency in USD

Bicara Therapeutics Inc. Earnings and Revenue History